Steven Cohen’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.3M Buy
+2,126,592
New +$18M 0.02% 900
2026
Q1
– Sell
-608,080
Closed -$4.77M – 4604
2025
Q4
$4.77M Buy
+608,080
New +$4.79M 0.01% 1881
2025
Q3
– Sell
-45,100
Closed -$211K – 2744
2025
Q2
$211K Sell
45,100
-43,273
-49% -$198K ﹤0.01% 1974
2025
Q1
$485K Buy
+88,373
New +$357K ﹤0.01% 1638
2023
Q4
– Sell
-655,000
Closed -$1.22M – 2922
2023
Q3
$1.22M Buy
+655,000
New +$1.5M ﹤0.01% 1269
2023
Q1
– Sell
-60,000
Closed -$79.8K – 2576
2022
Q4
$79.8K Buy
+60,000
New +$84.7K ﹤0.01% 1317
2020
Q3
– Sell
-232,410
Closed -$618K – 1122
2020
Q2
$618K Buy
+232,410
New +$809K ﹤0.01% 701
2018
Q3
– Sell
-5,000
Closed -$95K – 1243
2018
Q2
$95K Buy
+5,000
New +$97.2K ﹤0.01% 933

Other funds holding XERS

Steven Cohen's XERS Position: Q3 2026 in Review

Steven Cohen opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 2,126,592 shares worth $20.3M. The stake represents 0.02% of the portfolio and ranks #900 among its holdings. This is a return to the name: Steven Cohen previously reported a position in XERS as recently as Q4 2025.

Steven Cohen first reported a position in XERS in Q2 2018 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Steven Cohen held 2,126,592 shares of Xeris Biopharma Holdings worth $20.3M as of Q3 2026.
  • Xeris Biopharma Holdings was a new Steven Cohen position in Q3 2026.
  • Xeris Biopharma Holdings made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #900 holding.
  • Steven Cohen first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 8 quarters since.
  • 246 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.